Neuronal Stem Cell Transplantation for Neurodegeneration

📖 Wiki Page

therapeutic717 wordssynced 2026-04-02

Neuronal Stem Cell Transplantation for Neurodegeneration

Introduction

<table class="infobox infobox-therapeutic">
<tr>
<th class="infobox-header" colspan="2">Neuronal Stem Cell Transplantation for Neurodegeneration</th>
</tr>
<tr>
<td class="label">Name</td>
<td>Neuronal Stem Cell Transplantation for Neurodegeneration</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Therapeutic</td>
</tr>
</table>

Neuronal Stem Cell Transplantation For Neurodegeneration is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

flowchart TD Neuronal_Stem_Cell_Transplanta["Neuronal Stem Cell Transplantation for Neurodege"] Neuronal_Stem_Cell_Transplanta["Introduction"] Neuronal_Stem_Cell_Transplanta -->|"related to"| Neuronal_Stem_Cell_Transplanta style Neuronal_Stem_Cell_Transplanta fill:#81c784,stroke:#333,color:#000 Neuronal_Stem_Cell_Transplanta["table"] Neuronal_Stem_Cell_Transplanta -->|"related to"| Neuronal_Stem_Cell_Transplanta style Neuronal_Stem_Cell_Transplanta fill:#81c784,stroke:#333,color:#000 Neuronal_Stem_Cell_Transplanta["class"] Neuronal_Stem_Cell_Transplanta -->|"related to"| Neuronal_Stem_Cell_Transplanta style Neuronal_Stem_Cell_Transplanta fill:#81c784,stroke:#333,color:#000 style Neuronal_Stem_Cell_Transplanta fill:#4fc3f7,stroke:#333,color:#000

...

Neuronal Stem Cell Transplantation for Neurodegeneration

Introduction

Overview

Mermaid diagram (expand to render)

Neuronal stem cell transplantation represents a promising therapeutic approach for neurodegenerative diseases, aiming to replace lost [neurons](/entities/neurons), provide neurotrophic support, modulate inflammation, and restore neural circuits. Multiple stem cell types are being investigated, each with distinct advantages and limitations. [@kriks2011]

Stem Cell Types

Embryonic Stem Cells (ESCs)

Source: Inner cell mass of blastocysts
Potential: Can differentiate into all neuronal subtypes
Concerns: Ethical issues, tumor formation risk, immune rejection

Induced Pluripotent Stem Cells (iPSCs)

Source: Patient-derived reprogrammed cells
Potential: Autologous transplantation possible, disease modeling
Concerns: Genetic instability, reprogramming artifacts, cost

Neural Stem Cells (NSCs)

Source: Fetal brain tissue or ESC/iPSC differentiation
Potential: Lineage-restricted, lower tumor risk
Concerns: Limited expansion, immune rejection

Mesenchymal Stem Cells (MSCs)

Source: Bone marrow, adipose tissue, umbilical cord
Potential: Immunomodulatory, neurotrophic support
Concerns: Limited neuronal differentiation

Induced Neuronal (iN) Cells

Source: Direct reprogramming of fibroblasts
Potential: Patient-specific neurons, no pluripotency
Concerns: Immaturity, integration

Mechanisms of Action

Cell Replacement

Direct substitution of lost neurons
Integration into existing neural circuits
Formation of appropriate synaptic connections

Neurotrophic Support

Secretion of BDNF, GDNF, NGF
Support of endogenous neuron survival
Promotion of axonal regeneration

Immunomodulation

Reduction of pro-inflammatory cytokines
Promotion of anti-inflammatory phenotypes
Protection of endogenous neurons

Paracrine Signaling

Exosome-mediated effects
Metabolic support
Angiogenesis promotion

Clinical Applications

Parkinson's Disease

Target: Dopaminergic neurons in substantia nigra
Cell types: ESC-derived DA neurons, iPSC-derived DA neurons
Trials: Multiple Phase I/II trials ongoing
Status: Promising but challenging

Huntington's Disease

Target: Medium spiny neurons in striatum
Cell types: ESC-derived GABAergic neurons
Trials: Phase I trials completed
Status: Early stage

Amyotrophic Lateral Sclerosis (ALS)

Target: Motor neurons in spinal cord
Cell types: NSC transplantation, MSC therapy
Trials: Multiple Phase I/II trials
Status: Safety established, efficacy unclear

Alzheimer's Disease

Target: Hippocampal neurons, cholinergic neurons
Cell types: NSCs, ESC-derived cholinergic neurons
Trials: Early-stage investigations
Status: Preclinical/early clinical

Stroke and Spinal Cord Injury

Target: Damaged neural tissue
Cell types: NSCs, MSCs
Trials: Multiple trials ongoing
Status: Some functional improvements

Clinical Considerations

Advantages

Disease modification: Potential to halt or reverse progression
Personalized medicine: Patient-specific iPSC lines
Combination potential: With gene therapy or small molecules

Challenges

Cell survival: Low survival rates after transplantation
Integration: Proper circuit integration is difficult
Immune rejection: Requires immunosuppression
Tumor risk: Especially with pluripotent stem cells
Delivery: Surgical implantation required
Cost: Extremely expensive

Safety Concerns

Teratoma formation: Risk with pluripotent cells
Overgrowth: Uncontrolled cell proliferation
Dyskinesias: Particularly in PD (from excess dopamine)
Seizures: Possible with certain transplants

Future Directions

3D organoids: Brain organoids for transplantation
Gene-edited cells: CRISPR-corrected patient cells
Combined therapies: Stem cells + gene therapy
Biomaterial scaffolds: Support cell survival and integration
In vivo reprogramming: Direct conversion in the brain

Background

The study of Neuronal Stem Cell Transplantation For Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development. [@takahashi2020]

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions. [@cunningham2015]

Additional evidence sources: [@glass2020]

External Links

[ClinicalTrials.gov - Stem Cell Neurodegeneration](https://clinicaltrials.gov/)
[International Society for Stem Cell Research](https://www.isscr.org/)
[CIRM - California Institute for Regenerative Medicine](https://www.cirm.ca.gov/)

References

[Lindvall O, et al. (2012), "Transplantation of mesenchvmal stem cells to enhance regeneration." Cell Stem Cell (2012)](https://pubmed.ncbi.nlm.nih.gov/22704471/)

[Kriks S, et al. (2011), "Dopamine neurons derived from ESCs." Nature (2011)](https://pubmed.ncbi.nlm.nih.gov/21617634/)

[Unknown, Takahashi J. (2020). "iPSC-based Parkinson's disease modeling." NPJ Parkinson's Disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32047854/)

[Cunningham M, et al. (2015), "Neural stem cell therapy for stroke." Annals of Neurology (2015)](https://pubmed.ncbi.nlm.nih.gov/25933563/)

[Glass JD, et al. (2020), "Cell therapy for ALS." Annals of Neurology (2020)](https://pubmed.ncbi.nlm.nih.gov/32880936/)

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

[Programmable Neuronal Circuit Repair via Epigenetic CRISPR](/hypothesis/h-9d22b570) — 0.45 · Target: NURR1, PITX3, neuronal identity transcription factors
[Nutrient-Sensing Epigenetic Circuit Reactivation](/hypothesis/h-4bb7fd8c) — 0.79 · Target: SIRT1
[CYP46A1 Overexpression Gene Therapy](/hypothesis/h-2600483e) — 0.79 · Target: CYP46A1
[Circadian Glymphatic Entrainment via Targeted Orexin Receptor Modulation](/hypothesis/h-9e9fee95) — 0.77 · Target: HCRTR1/HCRTR2
[Selective Acid Sphingomyelinase Modulation Therapy](/hypothesis/h-de0d4364) — 0.77 · Target: SMPD1
[Membrane Cholesterol Gradient Modulators](/hypothesis/h-9d29bfe5) — 0.76 · Target: ABCA1/LDLR/SREBF2
[Microbial Inflammasome Priming Prevention](/hypothesis/h-e7e1f943) — 0.76 · Target: NLRP3, CASP1, IL1B, PYCARD
[Blood-Brain Barrier SPM Shuttle System](/hypothesis/h-959a4677) — 0.75 · Target: TFRC

Related Analyses:

[Selective vulnerability of entorhinal cortex layer II neurons in AD](/analysis/SDA-2026-04-01-gap-004) 🔄
[4R-tau strain-specific spreading patterns in PSP vs CBD](/analysis/SDA-2026-04-01-gap-005) 🔄
[4R-tau strain-specific spreading patterns in PSP vs CBD](/analysis/SDA-2026-04-01-gap-005) 🔄
[TDP-43 phase separation therapeutics for ALS-FTD](/analysis/SDA-2026-04-01-gap-006) 🔄
[Astrocyte reactivity subtypes in neurodegeneration](/analysis/SDA-2026-04-01-gap-007) 🔄

📖 View canonical wiki page →

Neuronal Stem Cell Transplantation for Neurodegeneration

Neuronal Stem Cell Transplantation for Neurodegeneration

Introduction

Overview

Neuronal Stem Cell Transplantation for Neurodegeneration

Introduction

Overview

Stem Cell Types

Embryonic Stem Cells (ESCs)

Induced Pluripotent Stem Cells (iPSCs)

Neural Stem Cells (NSCs)

Mesenchymal Stem Cells (MSCs)

Induced Neuronal (iN) Cells

Mechanisms of Action

Cell Replacement

Neurotrophic Support

Immunomodulation

Paracrine Signaling

Clinical Applications

Parkinson's Disease

Huntington's Disease

Amyotrophic Lateral Sclerosis (ALS)

Alzheimer's Disease

Stroke and Spinal Cord Injury

Clinical Considerations

Advantages

Challenges

Safety Concerns

Future Directions

See Also

Background

External Links

References

Related Hypotheses